We are live on
!
Find out more
TCMP
Thrive Capital Management (Pennsylvania) Portfolio holdings
AUM
$530M
1-Year Est. Return
22.41%
This Fund
S&P 500
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+22.41%
3 Year Est. Return
+58.21%
5 Year Est. Return
+53.58%
10 Year Est. Return
–
AUM
$187M
AUM Growth
+$6.58M
(+3.7%)
Cap. Flow
-$8.94M
Cap. Flow
% of AUM
-4.78%
Top 10 Holdings %
Top 10 Hldgs %
38.14%
Holding
161
New
24
Increased
45
Reduced
84
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$580K |
| 2 |
Costco
COST
|
+$360K |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$326K |
| 4 |
UnitedHealth
UNH
|
+$298K |
| 5 |
Microsoft
MSFT
|
+$273K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core Dividend Growth ETF
DGRO
|
+$1.06M |
| 2 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$1.02M |
| 3 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$1.01M |
| 4 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$932K |
| 5 |
iShares Core Conservative Allocation ETF
AOK
|
+$914K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.19% |
| 2 | Healthcare | 3.19% |
| 3 | Financials | 2.76% |
| 4 | Consumer Discretionary | 2.11% |
| 5 | Communication Services | 1.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CVS Health
CVS
$122B
| $200K | 0.11% |
2,533
-60
| -2% | -$4.27K |
|
152
Amcor
AMCR
$22.1B
| $170K | 0.09% |
3,534
-1,140
| -24% | -$52.4K |
|
153
Banco Santander
SAN
$210B
| $86.5K | 0.05% |
20,902
+2,169
| +12% | +$8.49K |
|
154
Iovance Biotherapeutics
IOVA
$2.87B
| $81.3K | 0.04% |
10,000
| – | – |
|
|
AUROW
155
Aurora Innovation Warrant
AUROW
$370M
| $6.08K | ﹤0.01% |
12,405
+1
| +0% | – |
|
|
LEV.WS
156
DELISTED
The Lion Electric Company Redeemable Warrants, each whole warrant entitles the holder to purchase one Common Share at a price of $11.50 per share
LEV.WS
| $526 | ﹤0.01% |
10,000
| – | – |
|
157
British American Tobacco
BTI
$128B
| – | – |
-8,494
| Closed | -$267K |
|
158
Colgate-Palmolive
CL
$74.4B
| – | – |
-6,238
| Closed | -$444K |
|
159
Canadian Imperial Bank of Commerce
CM
$108B
| – | – |
-5,534
| Closed | -$214K |
|
160
Unilever
UL
$136B
| – | – |
-6,011
| Closed | -$334K |
|
161
Vanguard FTSE Developed Markets ETF
VEA
$237B
| – | – |
-5,012
| Closed | -$219K |
|
Similar funds
UFF
TM
KI
PWS
SLC
LSCM
LIM
DA
Thrive Capital Management (Pennsylvania)'s Q4 2023 Portfolio in Review
As of Q4 2023, Thrive Capital Management (Pennsylvania) held 161 positions worth $187M, up 3.7% from $180M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Thrive Capital Management (Pennsylvania) withdrew a net $8.94M in Q4 2023, closing 5 positions and reducing 84 holdings. Its most notable exit was Colgate-Palmolive, an estimated $444K position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 4.3% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Thrive Capital Management (Pennsylvania) opened a new position in Costco worth $401K.
- Thrive Capital Management (Pennsylvania)'s largest Q4 2023 buy was Costco: 608 shares worth $401K.
- Thrive Capital Management (Pennsylvania) added most to Apple in Q4 2023, an estimated $580K increase.
- Thrive Capital Management (Pennsylvania)'s biggest Q4 2023 reduction was iShares Core Dividend Growth ETF, cutting an estimated $1.06M.
- Thrive Capital Management (Pennsylvania) fully exited Colgate-Palmolive in Q4 2023, selling an estimated $444K.
- Thrive Capital Management (Pennsylvania)'s ten largest holdings make up 38% of its $187M portfolio in Q4 2023.
- Thrive Capital Management (Pennsylvania) opened 24 new positions and closed 5 in Q4 2023.
- Thrive Capital Management (Pennsylvania)'s portfolio value rose 3.7% quarter-over-quarter to $187M.
Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q4 2023, filed 29 Jan 2024.